Symbol | Exchange | Currency |
|---|
By Leroy Leo and Aditya Samal (Reuters) - Johnson & Johnson (NYSE:JNJ) will look for opportunities to merge with or acquire firms that add value to its focus areas of eye care,...
By Scott Kanowsky Investing.com -- Amgen Inc. (NASDAQ:AMGN) has agreed to buy Horizon Therapeutics PLC (NASDAQ:HZNP) in an all-cash deal that values the biotech firm at about...
Last August, a little section of U.S. President Joe Biden’s much-touted Inflation Reduction Act caught the attention of investors. It introduced a 1% tax on stock...
Cardinal Health Inc (NYSE:CAH). CAH is well-poised for growth on the back of a diversified product portfolio, acquisition-driven strategy and robust pharmaceutical segment....
As the new year begins, analysts on Wall Street are debating which sectors might do well in 2022. Some highlight how the ongoing pandemic, supply chain issues, chip shortages and...
Abiomed, Inc. engages in the research, development, and sale of medical devices to assist or replace the pumping function of the failing heart. It also provides a continuum of care to heart failure patients. The company offers Impella 2.5, a percutaneous micro-heart pump with an integrated motor and sensors, and Impella CP, a device for use by interventional cardiologists to support patients in the cath lab as well as by cardiac surgeons in the heart surgery suite. It also provides Impella 5.0, Impella LD, and Impella 5.5, which are percutaneous micro-heart pumps with integrated motors and sensors for use primarily in the heart surgery suite; Impella RP, a percutaneous catheter-based axial flow pump; the Impella SmartAssist platform, which includes optical sensor technology for improved pump positioning and the use of algorithms that enable improved native heart assessment during the weaning process; Impella Connect, a cloud-based technology that enables secure and remote viewing of the automated impella controller for physicians and hospital staff; and the OXY-1 System, a portable external respiratory assistance device. In addition, the company is developing Impella ECP, a pump for blood flow of greater than three liters per minute; Impella XR Sheath, a sheath that expands and recoils allowing small bore access and closure with Impella heart pumps; Impella BTR, a percutaneous micro heart pump with integrated motors and sensors; and preCARDIA, a catheter-mounted superior vena cava therapy system designed to rapidly treat acutely decompensated heart failure. Abiomed, Inc. sells its products through direct sales and clinical support personnel in Germany, France, the United States, Japan, Europe, Canada, Latin America, the Asia-Pacific, and the Middle East. The company was founded in 1981 and is headquartered in Danvers, Massachusetts with additional offices in Halethorpe, Maryaland, Aachen, and Berlin, Germany, and Tokyo, Japan. As of December 22, 2022, Abiomed, Inc. operates as a subsidiary of Johnson & Johnson.
Type | 5 Min | 15 Min | Hourly | Daily | Monthly |
|---|---|---|---|---|---|
| Moving Averages | Strong Buy | Strong Buy | Strong Buy | Strong Buy | Strong Buy |
| Technical Indicators | Strong Buy | Buy | Strong Buy | Strong Buy | Strong Buy |
| Summary | Strong Buy | Strong Buy | Strong Buy | Strong Buy | Strong Buy |
Name | Last | High | Low | Chg. | Chg. % | Vol. | Time | ||
|---|---|---|---|---|---|---|---|---|---|
| 90.77 | 91.34 | 89.60 | +2.18 | +2.46% | 14.26M | NYSE | |||
| 59.39 | 60.60 | 58.58 | +1.41 | +2.43% | 4.67M | NYSE | |||
| 1.89 | 1.90 | 1.77 | +0.100 | +5.59% | 37.58K | NASDAQ | |||
| 0.00 | 0.00 | 0.00 | 0.00 | 0.00% | 0.00 | OTC Markets | |||
| 2.06 | 2.08 | 1.935 | +0.070 | +3.52% | 894.42K | NASDAQ | |||
| 35.43 | 36.18 | 35.31 | +0.90 | +2.61% | 10.31M | NASDAQ | |||
| 54.79 | 55.34 | 53.77 | +1.36 | +2.55% | 6.30M | NYSE | |||
| 21.90 | 21.95 | 21.50 | +0.53 | +2.48% | 377.32K | NYSE | |||
| 38.97 | 39.65 | 38.06 | +0.95 | +2.50% | 7.44M | NASDAQ | |||
| 22.42 | 22.42 | 22.42 | 0.00 | 0.00% | 0.00 | OTC Markets | |||
| 7.56 | 7.99 | 7.56 | +0.02 | +0.27% | 61.44M | NYSE | |||
| 2.35 | 2.40 | 2.216 | +0.090 | +3.98% | 37.00K | NASDAQ | |||
| 206.59 | 208.82 | 202.85 | +1.42 | +0.69% | 362.82K | NASDAQ | |||
| 17.25 | 17.25 | 17.02 | +0.22 | +1.29% | 3.48K | NYSE | |||
| 31.88 | 32.33 | 31.28 | +0.39 | +1.24% | 955.35K | NASDAQ |